$119.65 +$1.64 (+1.39%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $120.00 +0.29%
开盘$116.38
昨收$118.01
当日区间$115.00 – $119.81
成交量1.49M
市值$24.39B
市盈率（TTM）61.0
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例102.8%-0.27 个百分点，较上季度
持仓机构数1,140+38 ，较上季度
内部人近期交易33次买入 / 17次卖出净买入
空头持仓比例4.95% 占流通股回补天数 5.3 · 截至 15 Oct 2026
卖空成交量占比22.7%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：+$38.73M（12个净流入日，8个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有40.6%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从5.06%降至4.95%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Allspring Global Investments, LLC | Mutual Fund | 2026/Q3 | +646,890 | 0.4% |
| AssetMark, Inc. | Mutual Fund | 2026/Q3 | +477,256 | 0.3% |
| Deka Investment GmbH | Mutual Fund | 2026/Q3 | +474,610 | 0.3% |
| Baker Bros. Advisors LP | Hedge Fund | 2026/Q3 | +312,565 | 15.2% |
| Virginia Retirement System | Government Pension Fund | 2026/Q3 | +299,014 | 0.4% |
| Pictet Asset Management Limited | Mutual Fund | 2026/Q3 | +262,372 | 0.5% |
| Todd Asset Management LLC | Mutual Fund | 2026/Q3 | +168,885 | 0.2% |
| KBC Asset Management NV | Mutual Fund | 2026/Q3 | +151,052 | 0.2% |
| Two Sigma Investments, LP | Hedge Fund | 2026/Q3 | +1,587,645 | 1.0% |
| HSBC Global Asset Management (UK) Limited | Mutual Fund | 2026/Q3 | +725,282 | 0.6% |
| Wellington Management Group | Mutual Fund | 2026/Q3 | +309,385 | 1.8% |
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +305,259 | 1.1% |
| Jane Street Group, LLC | Private Company | 2026/Q3 | +260,561 | 0.1% |
| KBC Asset Management NV | Mutual Fund | 2026/Q3 | +243,628 | 0.1% |
| Armistice Capital LLC | Hedge Fund | 2026/Q3 | +243,188 | 0.4% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 14 Oct 2026 | Pablo Cagnoni | President and Global Head of R&D | Derivative Exercise and Sale | -2,642 | $112.71 | – |
| 30 Sep 2026 | Lee Heeson | Executive VP & Head of Incyte International | Sale to Issuer | -463 | $117.14 | 10,694 |
| 29 Sep 2026 | Edmund Harrigan | Independent Director | Other Acquisition | +206 | $121.35 | 21,583 |
| 29 Sep 2026 | Baker Bros. Advisors LP | Other Acquisition | +644 | – | 31,074,895 | |
| 29 Sep 2026 | Paul Clancy | Independent Director | Other Acquisition | +203 | $121.35 | 24,196 |
| 21 Sep 2026 | David Gardner | Chief Strategy Officer | Sale to Issuer | -920 | $126.93 | 1,437 |
| 14 Sep 2026 | Pablo Cagnoni | President and Global Head of R&D | Derivative Exercise and Sale | -23,218 | $120.50 | – |
| 24 Aug 2026 | Soni Basi | Executive Vice President | Sale to Issuer | -504 | $129.72 | 5,245 |
| 18 Aug 2026 | Pablo Cagnoni | President and Global Head of R&D | Open Market Disposition | -10,801 | $125.56 | – |
| 11 Aug 2026 | Pablo Cagnoni | President and Global Head of R&D | Open Market Disposition | -10,803 | $120.04 | 10,801 |
| 4 Aug 2026 | Pablo Cagnoni | President and Global Head of R&D | Open Market Disposition | -10,640 | $122.69 | 21,604 |
| 4 Aug 2026 | Patrick Mayes | Vice President of Biotherapeutic Research | Derivative Exercise and Sale | -2,207 | $123.99 | 1,904 |
| 2 Aug 2026 | Patrick Mayes | Vice President of Biotherapeutic Research | Derivative Exercise and Sale | -45,767 | $122.19 | 1,904 |
| 30 Jul 2026 | Pablo Cagnoni | President and Global Head of R&D | Open Market Disposition | -15,888 | $119.70 | 32,244 |
| 30 Jul 2026 | Patrick Mayes | Vice President of Biotherapeutic Research | Open Market Disposition | -2,187 | $119.41 | 1,904 |
| 22 Jul 2026 | Michael Morrissey | Executive VP & Head of Global Technical Operations | Other Derivative Acquisition | +6,426 | $116.69 | 6,426 |
| 22 Jul 2026 | Michael Morrissey | Executive VP & Head of Global Technical Operations | Other Derivative Acquisition | +8,999 | – | 8,999 |
| 22 Jul 2026 | Lee Heeson | Executive VP & Head of Incyte International | Other Derivative Acquisition | +13,498 | – | 13,498 |
| 22 Jul 2026 | Lee Heeson | Executive VP & Head of Incyte International | Other Derivative Acquisition | +15,423 | $116.69 | 15,423 |
| 15 Jul 2026 | Pablo Cagnoni | President and Global Head of R&D | Other Acquisition | +13,403 | – | 183,200 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 10,025,354 | 4.9% | 5.3 |
| 30 Sep 2026 | 9,987,084 | 4.9% | 6.1 |
| 15 Sep 2026 | 9,981,369 | 4.9% | 7.3 |
| 31 Aug 2026 | 9,364,687 | 4.6% | 7.7 |
| 14 Aug 2026 | 9,389,500 | 4.6% | 6.7 |
| 31 Jul 2026 | 10,246,477 | 5.1% | 4.8 |
暂无评论——快来第一个聊聊 INCY。
登录后参与讨论。